Clinical trial
Intra-operative Pancreatoscopy in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN)
NCT03729453 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intra-operative Pancreatoscopy in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN)
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 20, 2019
- Completion date
- May 31, 2027
- Enrollment
- 100 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
intraductal papillary mucinous neoplasm